Elzonris
NDC 72187-0401, tagraxofusp, injection, solution, from Stemline Therapeutics, Inc..
- Product NDC
- 72187-0401
- Status
- Listed
- Labeler
- Stemline Therapeutics, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761116
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72187-0401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TAGRAXOFUSP1000 ug/mL
Pharmacologic classes
CD123 Interaction [EPC]; CD123 Interactions [MoA]; Cytotoxin [EPC]; Cytotoxins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72187-0401-1 | 72187040101 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72187-0401-1) / 1 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/80eb1080-fe20-4af0-b2a5-a67999923fa8Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=72187-0401
Use it
Look up 72187-0401 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72187-0401 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72187-0401. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.